2013
DOI: 10.1007/s40266-013-0074-z
|View full text |Cite
|
Sign up to set email alerts
|

Medication (Re)fill Adherence Measures Derived from Pharmacy Claims Data in Older Americans: A Review of the Literature

Abstract: Medication nonadherence is a significant public health problem that affects the health and well-being of older Americans while burdening the US healthcare system. Pharmacy claims data have gained importance in deriving objective medication (re)fill adherence measures; however, little is known about application of such measures in older Americans. The objective of this study was to assess the types and characteristics of pharmacy claims-derived medication (re)fill adherence measures used in older Americans. A c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
99
0
4

Year Published

2015
2015
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 116 publications
(106 citation statements)
references
References 50 publications
2
99
0
4
Order By: Relevance
“…First, PDC assesses only the availability of medication and not the actual taking of medication. However, use of measures, like PDC, which rely on administrative data to assess nonadherence have typically correlated well with self-reported nonadherence, plasma medication levels, physiologic markers, and cardiovascular disease outcomes (2,22), and might better assess nonadherence among older adults than self-reported or other objective measures (22). Second, because the PDC calculation excludes patients with only one antihypertensive fill and does not include persons who are prescribed medication but never initiate treatment, it probably underestimates nonadherence.…”
Section: Conclusion and Commentsmentioning
confidence: 99%
“…First, PDC assesses only the availability of medication and not the actual taking of medication. However, use of measures, like PDC, which rely on administrative data to assess nonadherence have typically correlated well with self-reported nonadherence, plasma medication levels, physiologic markers, and cardiovascular disease outcomes (2,22), and might better assess nonadherence among older adults than self-reported or other objective measures (22). Second, because the PDC calculation excludes patients with only one antihypertensive fill and does not include persons who are prescribed medication but never initiate treatment, it probably underestimates nonadherence.…”
Section: Conclusion and Commentsmentioning
confidence: 99%
“…These methods are useful tools for helping to predict future health care utilisation and costs (Karve et al, 2009;Sattler, Lee, & Perri, 2013). However, they are undermined by the assumption that refilling a medication corresponds to actual medicationtaking behaviour, and do not provide information about when or how medication is actually taken.…”
Section: Measuring Medication Adherencementioning
confidence: 99%
“…PDC is the accumulation of days the medication is available (or 'covered') within a pre-determined observation period, divided by the number of days in that period, and multiplied by 100. MPR and PDC were used as continuous variables and also as dichotomised variables using ≄80% as a widely used cut-off between good and poor adherers (Karve et al, 2009;Sattler et al, 2013).…”
Section: Clinical and Treatment Characteristicsmentioning
confidence: 99%
“…Outra limitação do estudo estĂĄ relacionada Ă  estimativa da nĂŁo adesĂŁo, que foi realizada por intermĂ©dio de um mĂ©todo indireto. A PDC Ă© avaliada como uma das principais medidas indiretas de ade-sĂŁo 37,38 . No entanto, o registro do fornecimento do medicamento nĂŁo indica indubitavelmente que o paciente o utilizou, mas sim que o medicamento ficou disponĂ­vel para uso durante determinado perĂ­odo.…”
Section: Discussionunclassified